EG quotes Louise Ward on the resilience of the life sciences sector in 2022
min readLife sciences real estate stood strong against the economic turmoil of 2022, although the market couldn’t match the peak reached in 2021. Venture capital investment continued to flow into the sector, boosting demand for life sciences space.
Louise Ward, Partner, provides comment for EG on how the life sciences industry fared in 2022 and industry trends heading in 2023.
She says:
“2022 has been a buoyant year for real estate transactions in the life sciences sector, characterised by a number of new entrants to the market making their mark, together with some high-profile deals and developments for some of the more established players in the market.
There has also been a rise in establishing partnerships or joint ventures. I would expect this trend to continue into 2023.”
Read the full article in EG here (subscription required).
